Loading...
| A15647 | Pages: NA | Jul 2022 | 123 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Toxoplasmosis Treatment Market
Request Now !Toxoplasmosis is an infection cause by a common parasite which is found in cat feces and in contaminated food. This parasite is known as Toxoplasma gondii. Symptoms such as body aches and pain, headache, fatigue, fever, and swollen lymph nodes occur in infected person. Moreover, in immune compromise people the symptoms occur such as confusion, blurry vision, and lung problems. Toxoplasmosis can be diagnosed through computed tomography scan, magnetic resonance imaging, contrast agents, biopsy and polymerase chain reaction, whereas pregnant women are treated with sulphadiazine and spiramycin drug. Clindamycin and pyrimethamine are used as an alternative treatment for toxoplasmosis.
.
Market Scope and Structure Analysis
Report Metric | Details |
Market Size Available for Years | 2020–2030 |
Base Year Considered | 2020 |
Forecast Period | 2021–2030 |
Forecast Unit | Value (USD) |
Segments Covered | Product Type, Application, Distribution Channel and Region |
COVID-19 Impact analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. This highly contagious disease, caused by a virus, is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that is transmitted from one person to another. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a pandemic on March 11, 2020.
Pharmaceutical and biotech companies together with governments all across the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. For instance, in May 2020, as per Ministry of Education and Science the scientist from the University of Szczecin, the University of Life Sciences in Poznan and their colleagues from hungary, france, and china has studied that there were connection between COVID-19 cases and toxoplasmosis spread by toxoplasma gondii. This in turn is expected to have a significant impact on the toxoplasmosis treatment market.
Top Impacting Factors
Market Trends
New product launches to flourish the market
In March 2020, Cerovene Inc. launched first generic version of Daraprim tablets (pyrimethamine) for the treatment of toxoplasmosis infection which can be used with sulfonamide.
Key Benefits of the Report
Questions answered in the toxoplasmosis Report
Key Market Segments
| Segments | Sub-segments |
|---|---|
| By Product Type |
|
| By Application |
|
| By Distribution Channel |
|
| By Region |
|
Key Market Players
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
